AstraZeneca's Drug Price Gamble: US Cuts, UK Hikes
Update: 2025-10-11
Description
AstraZeneca cuts U.S. drug prices under Trump pressure, gets tariff break, and invests $50B, but threatens to pull U.K. investments over NHS payment disputes, sparking market turmoil and raising questions about global drug pricing fairness.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
